FCF Life Sciences Venture Capital Monitor – Europe 12/2021 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2021”.

The Monitor is a monthly published overview of venture capital trends in the European Life Sciences sector.

As of the end of December 2021 we identify the following current VC trends in Europe:

  • In 2021, overall Life Sciences funding has reached EUR 13,874m
  • Top 5 Deals exceed EUR 200m each, largest transaction amounted to EUR 497m in CMR Surgical Ltd. (United Kingdom)
  • Novo Holdings (Denmark) dominates the Top 5 Investors (by deal volume), followed by BlackRock (USA) and Fidelity Management & Research (USA)
  • The MedTech sector received 32% of the total investment volume (-5% points compared to the previous month)
  • Central Nervous System dominates as the top indication of the Biotechnology sector

To access the full report, please click here.

By Dr. Mathias Schott and Sebastian Sommer

Share
[a-zA-Z0-9_.-]
[a-zA-Z0-9_.-]
[a-zA-Z0-9]
[a-zA-Z0-9]